Atai Life Sciences Net Income 2020-2023 | ATAI
Atai Life Sciences Annual Net Income (Millions of US $) |
|
---|---|
2022 | $-152 |
2021 | $-168 |
2020 | $-170 |
2019 | $-14 |
Atai Life Sciences Quarterly Net Income (Millions of US $) |
|
---|---|
2023-09-30 | $44 |
2023-06-30 | $-33 |
2023-03-31 | $-33 |
2022-12-31 | $-45 |
2022-09-30 | $-34 |
2022-06-30 | $-37 |
2022-03-31 | $-37 |
2021-12-31 | $-89 |
2021-09-30 | $-31 |
2021-06-30 | $-48 |
2021-03-31 | $1 |
2020-12-31 | $-87 |
2020-09-30 | $-83 |
2020-06-30 | $-16 |
2020-03-31 | $16 |
2019-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical - Outpatient & Home Care | $0.357B | $0.000B |
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Fresenius SE (FSNUY) | Germany | $15.906B | 9.62 |
Quest Diagnostics (DGX) | United States | $14.151B | 14.63 |
DaVita (DVA) | United States | $11.382B | 15.49 |
Chemed (CHE) | United States | $9.221B | 29.02 |
Encompass Health (EHC) | United States | $8.008B | 21.97 |
Elanco Animal Health (ELAN) | United States | $6.724B | 15.33 |
Option Care Health (OPCH) | United States | $5.444B | 21.31 |
RadNet (RDNT) | United States | $3.279B | 95.78 |
Amedisys (AMED) | United States | $2.981B | 21.27 |
LifeStance Health (LFST) | United States | $2.139B | 0.00 |
Astrana Health (ASTH) | United States | $2.100B | 26.50 |
Addus HomeCare (ADUS) | United States | $1.574B | 24.13 |
U.S Physical Therapy (USPH) | United States | $1.495B | 38.76 |
Pennant (PNTG) | United States | $0.608B | 35.10 |
Aveanna Healthcare Holdings (AVAH) | United States | $0.439B | 0.00 |
Daxor (DXR) | United States | $0.045B | 0.00 |
MEDIROM Healthcare Technologies (MRM) | Japan | $0.029B | 0.00 |
ATI Physical Therapy (ATIP) | United States | $0.018B | 0.00 |
Psychemedics (PMD) | United States | $0.015B | 0.00 |
Ontrak (OTRK) | United States | $0.013B | 0.00 |
Novo Integrated Sciences (NVOS) | United States | $0.012B | 0.00 |
IMAC Holdings (BACK) | United States | $0.005B | 0.00 |